Here, we show that the myokine profile of JDM patients significantly differs from healthy controls, and that the increase in proinflammatory myokines seen in JDM can be recapitulated in the IFN-stimulated myobundle model via gene and protein expression. This evidence concerns the gene IFNA1 and juvenile dermatomyositis.